Pharma & Biotech

CVC Strategic Opportunities Sells Entire Stake in Genetic S.p.A., Strengthening the Company’s Global Position

(IN BRIEF) CVC Strategic Opportunities II has successfully exited its investment in Genetic S.p.A., a pharmaceutical CDMO specializing in Respiratory,…

5 months ago

AstraZeneca’s Breztri Aerosphere Shows Positive Phase III Results for Uncontrolled Asthma Treatment

(IN BRIEF) Positive results from the Phase III KALOS and LOGOS trials show that AstraZeneca's Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) significantly…

5 months ago

Merck to Acquire SpringWorks Therapeutics, Expanding Leadership in Rare Tumors and Advancing Healthcare Innovation

(IN BRIEF) Merck has entered into a definitive agreement to acquire SpringWorks Therapeutics for approximately $3.9 billion. This acquisition will…

6 months ago